Arena Pharmaceuticals, Inc. Financials

Market Capitalization $6.17 Billion as of March 1, 2022

Valuations Metrics as of Jul. 4, 2025

Trailing PE	9.96
Forward PE	8.65
Price to Sales TTM	Rp1.56
Price to Book MRQ	Rp2.16
Enterprise to Revenue	1.46
Enterprise to EBITDA	5.92

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	15.84%
Operating Margin	20.07%
Return on Assets TTM	12.57%
Return on Equity TTM	23.90%

Income Statement

Revenue TTM	Rp2,690,734,096,384
Revenue per Share TTM	Rp374.02
Quarterly Revenue Growth	9.20%
Gross Profit TTM	Rp900,076,732,416
EBITDA	Rp559,625,087,801
Net Income to Common TTM	Rp426,180,116,480
Diluted EPS TTM	Rp59.24
Quarterly Earnings Growth YoY	0.20%

Balance Sheet

Total Cash MRQ	Rp442,658,062,336
Total Cash per Share MRQ	Rp62.65
Total Debt MRQ	Rp
Total Debt to Equity MRQ	5.28
Current Ratio MRQ	2.14
Book Value per Share MRQ	Rp273.36

Cash Flow

Operating Cash Flow TTM	Rp645,274,599,424
Levered Free Cash Flow TTM	Rp-7,222,176,256

ARNA Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	7,093,241,376
Float Shares	3,255,725,079
Avg 10 Volume	1,438,260
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.90%
% Held by Institutions	15.35%

Stock Price Summary

Beta	0.45
Fifty Two Week Low	Rp565.00
Fifty Two Week High	Rp800.00
Fifty Two Week Change	-5.93%
Day 50 MA	Rp605.20
Day 200 MA	Rp658.68

Dividends and Splits

Forward Annual Dividend Rate	Rp172.00
Forward Annual Dividend Yield	29.15%
Trailing Annual Dividend Rate	Rp43.00
Trailing Annual Dividend Yield	7.29%
Payout Ratio	72.59%
Dividend Date
Ex Dividend Date	2025-04-17
Last Split Factor
Last Split Date	2013-07-08